KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Investing Activities (2016 - 2025)

Biogen (BIIB) has 17 years of Cash from Investing Activities data on record, last reported at -$1.2 billion in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 6522.04% year-over-year to -$1.2 billion; the TTM value through Dec 2025 reached -$1.4 billion, down 71.56%, while the annual FY2025 figure was -$1.4 billion, 71.56% down from the prior year.
  • Cash from Investing Activities reached -$1.2 billion in Q4 2025 per BIIB's latest filing, down from -$35.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.7 billion in Q3 2022 and bottomed at -$1.7 billion in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$262.9 million, with a median of -$126.9 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 815.84% in 2022, then crashed 6522.04% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$112.7 million in 2021, then dropped by 25.2% to -$141.1 million in 2022, then plummeted by 362.3% to -$652.3 million in 2023, then skyrocketed by 97.15% to -$18.6 million in 2024, then plummeted by 6522.04% to -$1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$1.2 billion in Q4 2025, -$35.1 million in Q3 2025, and -$57.0 million in Q2 2025.